Clinical Trial Update: Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01)

View source ↗

Summary

This entry reports on the PDO-Mercurial01 trial using patient-derived breast cancer organoids for therapeutic extracellular vesicle isolation. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Istituti Clinici Scientifici Maugeri SpA | Conditions: Invasive Breast Cancer | Status: ACTIVE_NOT_RECRUITING